{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:36:46Z","timestamp":1787877406013,"version":"build-2784847793"},"reference-count":47,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1684\/ejd.2018.3490","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T11:23:38Z","timestamp":1696850618000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders"],"prefix":"10.1684","volume":"29","author":[{"given":"Keiji","family":"Iwatsuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenobu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"key":"3490_CR1","first-page":"355","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"L Quintanilla-Martinez","year":"2017","unstructured":"Quintanilla-Martinez L, Ko YH, Kimura H, Jaffe ES. EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th Ed. Swerdlow SH, Campo E, Harris NL, et al. Lyon: WHO Press, 2017: 355\u201363.","edition":"4th"},{"key":"3490_CR2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443","volume":"96","author":"L Quintanilla-Martinez","year":"2000","unstructured":"Quintanilla-Martinez L, Kumar S, Fend F, et al. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 2000; 96: 443\u201351.","journal-title":"Blood"},{"key":"3490_CR3","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","volume":"20","author":"JI Cohen","year":"2009","unstructured":"Cohen JI, Kimura H, Nakamura S, Ko Y-H, Jaffe ES. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts. Ann Oncol 2009; 20: 1472\u201382.","journal-title":"Ann Oncol"},{"key":"3490_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/archderm.142.5.587","volume":"142","author":"K Iwatsuki","year":"2006","unstructured":"Iwatsuki K, Satoh M, Yamamoto T, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 2006; 142: 587\u201395.","journal-title":"Arch Dermatol"},{"key":"3490_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/blood.V98.2.280","volume":"98","author":"H Kimura","year":"2001","unstructured":"Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001; 98: 280\u20136.","journal-title":"Blood"},{"key":"3490_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in non-immunocompromised hosts: prospective analysis of 108 cases. Blood 2012; 119: 673\u201386.","journal-title":"Blood"},{"key":"3490_CR7","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/jid.2011.461","volume":"132","author":"Y Hirai","year":"2012","unstructured":"Hirai Y, Yamamoto T, Kimura H, et al. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected \u03b3\u03b4T cells. J Invest Dermatol 2012; 132: 1401\u20138.","journal-title":"J Invest Dermatol"},{"key":"3490_CR8","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1086\/605610","volume":"200","author":"H Kimura","year":"2009","unstructured":"Kimura H, Miyake K, Yamauchi Y, et al. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases. J Infect Dis 2009; 200: 1078\u201387.","journal-title":"J Infect Dis"},{"key":"3490_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1365-2133.2011.10512.x","volume":"166","author":"C Tanaka","year":"2012","unstructured":"Tanaka C, Hasegawa M, Fujimoto M, et al. Phenotypic analysis in a case of hydroa vacciniforme-like eruptions associated with chronic active Epstein-Barr virus disease of \u03b3\u03b4 T cells. Br J Dermatol 2012; 166: 216\u20138.","journal-title":"Br J Dermatol"},{"key":"3490_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/367988","volume":"187","author":"H Kimura","year":"2003","unstructured":"Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 2003; 187: 527\u201333.","journal-title":"J Infect Dis"},{"key":"3490_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","volume":"58","author":"K Ohshima","year":"2008","unstructured":"Ohshima K, Kimura H, Yoshino T, et al. Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lympho-proliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 2008; 58: 209\u201317.","journal-title":"Pathol Int"},{"key":"3490_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/bjd.13411","volume":"172","author":"T Miyake","year":"2015","unstructured":"Miyake T, Yamamoto T, Hirai Y, et al. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites. Br J Dermatol 2015; 172: 56\u201363.","journal-title":"Br J Dermatol"},{"key":"3490_CR13","first-page":"599","volume":"1","author":"PAE Bazin","year":"1862","unstructured":"Bazin PAE. Lecons th\u00e9oriques et cliniques sur les affections g\u00e9n\u00e9riques de la peau; tom 1, 1862: 599.","journal-title":"Lecons th\u00e9oriques et cliniques sur les affections g\u00e9n\u00e9riques de la peau"},{"key":"3490_CR14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1684\/ejd.2012.1665","volume":"22","author":"T Yamamoto","year":"2012","unstructured":"Yamamoto T, Hirai Y, Miyake T, Yamasaki O, Morizane S, Iwatsuki K. Oculomucosal and gastrointestinal involvement in Epstein-Barr virus-associated hydroa vacciniforme. Eur J Dermatol 2012; 22: 380\u20133.","journal-title":"Eur J Dermatol"},{"key":"3490_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1046\/j.1365-2133.1999.02777.x","volume":"140","author":"K Iwatsuki","year":"1999","unstructured":"Iwatsuki K, Xu Z, Takata M, et al. The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol 1999; 140: 715\u201321.","journal-title":"Br J Dermatol"},{"key":"3490_CR16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1365-2133.2005.06849.x","volume":"153","author":"S Morizane","year":"2005","unstructured":"Morizane S, Suzuki D, Tsuji K, Oono T, Iwatsuki K. The role of CD4 and CD8 cytotoxic T lymphocytes in the formation of viral vesicles. Br J Dermatol 2005; 153: 981\u20136.","journal-title":"Br J Dermatol"},{"key":"3490_CR17","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1001\/archderm.1986.01660230098020","volume":"122","author":"T Oono","year":"1986","unstructured":"Oono T, Arata J, Masuda T, Ohtsuki Y. Coexistence of hydroa vacciniforme and malignant lymphoma. Arch Dermatol 1986; 122: 1306\u20139.","journal-title":"Arch Dermatol"},{"key":"3490_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/0190-9622(95)90409-3","volume":"32","author":"N Tabata","year":"1995","unstructured":"Tabata N, Aiba S, Ichinohazama R, et al. Hydroa vacciniforme-like lymphomatoid papulosis in a Japanese child: a new subset. J Am Acad Dermatol 1995; 32: 378\u201381.","journal-title":"J Am Acad Dermatol"},{"key":"3490_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1346-8138.2003.tb00406.x","volume":"30","author":"Y Katagiri","year":"2003","unstructured":"Katagiri Y, Mitsuhashi Y, Kondo S, Kanazawa C, Iwatsuki K, Tsunoda T. Hydroa vacciniforme-like eruptions in a patient with chronic active EB virus infection. J Dermatol 2003; 30: 400\u20134.","journal-title":"J Dermatol"},{"key":"3490_CR20","first-page":"503","volume":"15","author":"Y Nitta","year":"2005","unstructured":"Nitta Y, Iwatsuki K, Kimura H, et al. Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders. EurJ Dermatol 2005; 15: 503\u20136.","journal-title":"EurJ Dermatol"},{"key":"3490_CR21","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1365-2133.1996.tb06994.x","volume":"134","author":"KH Cho","year":"1996","unstructured":"Cho KH, Kim CW, Lee DY, Sohn SJ, Kim DW, Chung JH. An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face. Br J Dermatol 1996; 134: 791\u20136.","journal-title":"Br J Dermatol"},{"key":"3490_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1525-1470.2010.01094.x","volume":"27","author":"Z Xu","year":"2010","unstructured":"Xu Z, Lian S. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children. Pediatr Dermatol 2010; 27: 463\u20139.","journal-title":"Pediatr Dermatol"},{"key":"3490_CR23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S0190-9622(98)70120-3","volume":"38","author":"M Magana","year":"1998","unstructured":"Magana M, Sangueza P, Gil-Beristain J, et al. Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma. J Am Acad Dermartol 1998; 38: 574\u20139.","journal-title":"J Am Acad Dermartol"},{"key":"3490_CR24","first-page":"7","volume":"10","author":"C Barrionuevo","year":"2002","unstructured":"Barrionuevo C, Anderson VM, Zevallos-Giampietri E, et al. Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. Appl Immunohistochem Mol Morphol 2002; 10: 7\u201314.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"3490_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.1365-2133.2002.04862.x","volume":"147","author":"HH Chen","year":"2002","unstructured":"Chen HH, Hsiao CH, Chiu HC. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma. Br J Dermatol 2002; 147: 587\u201391.","journal-title":"Br J Dermatol"},{"key":"3490_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1365-2133.2004.06038.x","volume":"151","author":"KH Cho","year":"2004","unstructured":"Cho KH, Lee SH, Kim CW, et al. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Br J Dermatol 2004; 151: 372\u201380.","journal-title":"Br J Dermatol"},{"key":"3490_CR27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1600-0560.2007.00836.x","volume":"35","author":"K Doeden","year":"2008","unstructured":"Doeden K, Molina-Kirsch H, Perez E, Warnke R, Sundram U. Hydroa-like lymphoma with CD56 expression. J Cutan Pathol 2008; 35: 488\u201394.","journal-title":"J Cutan Pathol"},{"key":"3490_CR28","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","volume":"122","author":"L Quintanilla-Martinez","year":"2013","unstructured":"Quintanilla-Martinez L, Ridaura C, Nagi F, et al. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. Blood 2013; 122: 3101\u201310.","journal-title":"Blood"},{"key":"3490_CR29","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.0022-202X.2005.23915.x","volume":"125","author":"H Asada","year":"2005","unstructured":"Asada H, Saito-Katsuragi M, Niizeki H, et al. Mosquito salivary gland extracts induce EBV-infected NK cell oncogenesis via CD4+ T cells in patients with hypersensitivity to mosquito bites. J Invest Dermatol 2005; 125: 956\u201361.","journal-title":"J Invest Dermatol"},{"key":"3490_CR30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1067\/mjd.2001.114751","volume":"45","author":"Y Tokura","year":"2001","unstructured":"Tokura Y, Ishihara S, Tagawa S, Seo N, Ohshima K, Takigawa M. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia\/lymphoma. J Am Acad Dermatol 2001; 45: 569\u201378.","journal-title":"J Am Acad Dermatol"},{"key":"3490_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/1346-8138.12446","volume":"41","author":"H Nomura","year":"2014","unstructured":"Nomura H, Egami S, Kasai H, et al. An elderly patient with chronic active Epstein-Barr virus infection with severe hydroa vacciniforme-like eruptions associated with \u03b1\u03b2T-cell proliferation. J Dermatol 2014; 41: 360\u20132.","journal-title":"J Dermatol"},{"key":"3490_CR32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s12185-011-0831-x","volume":"93","author":"A Arai","year":"2011","unstructured":"Arai A, Imadome K, Watanabe Y, et al. Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis. Int J Hematol 2011; 93: 602\u20139.","journal-title":"Int J Hematol"},{"key":"3490_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcv.2011.01.014","volume":"51","author":"S Ohga","year":"2011","unstructured":"Ohga S, Ishimura M, Yoshimoto G, et al. Clonal origin of Epstein-Barr virus (EBV)-infected T\/NK-cell subpopulations in EBV-positive T\/NK-cell lymphoproliferative disorders of childhood. J Clin Virol 2011; 51: 31\u20137.","journal-title":"J Clin Virol"},{"key":"3490_CR34","unstructured":"Ito Y, Suzuki R, Torii Y, et al. HLA-A*26 and HLA-B*52 are associated with a risk of developing EBV-associated T\/NK lymphoproliferative disease. Blood 2013, Available at: http:\/\/www.bloodjournal.org\/content\/early\/2011\/11\/16\/blood-2011-10-381921\/tab-e-letters."},{"key":"3490_CR35","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","volume":"115","author":"Y Huang","year":"2010","unstructured":"Huang Y, de Reynies A, de Leval L, et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type. Blood 2010; 115: 1226\u201337.","journal-title":"Blood"},{"key":"3490_CR36","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","volume":"118","author":"K Karube","year":"2011","unstructured":"Karube K, Nakagawa M, Tsuzuki S, et al. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analysis. Blood 2011; 118: 3195\u2013204.","journal-title":"Blood"},{"key":"3490_CR37","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ng.3358","volume":"47","author":"L Jiang","year":"2015","unstructured":"Jiang L, Gu ZH, Yan ZX, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma. Nat Genet 2015; 47: 1061\u20136.","journal-title":"Nat Genet"},{"key":"3490_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/cid\/ciw160","volume":"63","author":"JI Cohen","year":"2016","unstructured":"Cohen JI, Dropulic L, Hsu AP, et al. Association of GATA2 deficiency with severe primary Epstein-Barr virus (EBV) infection and EBV-associated cancers. Clin Infect Dis 2016; 63: 41\u20137.","journal-title":"Clin Infect Dis"},{"key":"3490_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2016.03.001","volume":"82","author":"T Yamamoto","year":"2016","unstructured":"Yamamoto T, Hirai Y, Miyake T, et al. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites. J Dermatol Sci 2016; 82: 153\u20139.","journal-title":"J Dermatol Sci"},{"key":"3490_CR40","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.exphem.2010.06.005","volume":"38","author":"D Suzuki","year":"2010","unstructured":"Suzuki D, Tsuji K, Yamamoto T, Fujii K, Iwatsuki K. Production of proinflammatory cytokines without invocation of cytotoxic effects by an Epstein-Barr virus-infected natural killer cell line established from a patient with hypersensitivity to mosquito bites. Exp Hematol 2010; 38: 933\u201344.","journal-title":"Exp Hematol"},{"key":"3490_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/10428194.2016.1179297","volume":"58","author":"JH Paik","year":"2017","unstructured":"Paik JH, Choe JY, Kim H, et al. Clinicopathological categorization of Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Leuk Lymphoma 2017; 58: 53\u201363.","journal-title":"Leuk Lymphoma"},{"key":"3490_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/bmt.2010.122","volume":"46","author":"K Kawa","year":"2011","unstructured":"Kawa K, Sawada A, Sato M, et al. Excellent outcome of allogenic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplant 2011; 46: 77\u201383.","journal-title":"Bone Marrow Transplant"},{"key":"3490_CR43","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1086\/587671","volume":"46","author":"K Gotoh","year":"2008","unstructured":"Gotoh K, Ito Y, Shibata-Watanabe Y, et al. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis 2008; 46: 1525\u201334.","journal-title":"Clin Infect Dis"},{"key":"3490_CR44","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ajh.21247","volume":"83","author":"E Sato","year":"2008","unstructured":"Sato E, Ohga S, Kuroda H, et al. Allogenic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease in Japan. Am J Hematol 2008; 83: 721\u20137.","journal-title":"Am J Hematol"},{"key":"3490_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2340\/00015555-2564","volume":"97","author":"A Toksoy","year":"2017","unstructured":"Toksoy A, Strifler S, Benoit S, et al. Hydroa vacciniforme-like skin lesions in Epstein-Barr-virus-associated T-cell lymphoproliferation with subsequent development of aggressive NK\/T-cell lymphoma. Acta Derm Venereol 2017; 97: 379\u201380.","journal-title":"Acta Derm Venereol"},{"key":"3490_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1532\/IJH97.05083","volume":"82","author":"M Koyama","year":"2005","unstructured":"Koyama M, Takeshita Y, Sakata A, et al. Cytotoxic chemotherapy successfully induces durable complete remission in 2 patients with mosquito allergy resulting from Epstein-Barr virus-associated T-\/natural killer cell lymphoproliferative disease. Int J Hematol 2005; 82: 437\u201340.","journal-title":"Int J Hematol"},{"key":"3490_CR47","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/ajh.23843","volume":"89","author":"BE Beltr\u00e1n","year":"2014","unstructured":"Beltr\u00e1n BE, Msaza I, Mois\u00e9s-Alfaro CB, et al. Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: report of four pediatric cases from Peru. Am J Hematol 2014; 89: 1160\u20131.","journal-title":"Am J Hematol"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2018.3490\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:17:44Z","timestamp":1741173464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3490"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2018.3490","relation":{},"ISSN":["1952-4013"],"issn-type":[{"value":"1952-4013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"15 August 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 Mai 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}